Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash flows from operating activities:
Net earnings	$ 3,382	$ 2,279
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation, amortization and accretion	3,915	3,519
Provision for loan losses	9,696	10,217
Gain on sale of investment securities	(2,495)	(1,791)
Write-down of investment securities	0	100
Loss/(Gain) on sale of other real estate and repossessions	181	(198)
Write-down of other real estate and repossessions	845	895
Restricted stock expense	5	7
Change in:
Mortgage loans held for sale	1,666	726
Cash surrender value of life insurance	(182)	(193)
Other assets	1,546	(643)
Other liabilities	438	(357)
Net cash provided by operating activities	18,997	14,561
Cash flows from investing activities:
Net change in certificates of deposit	735	2,610
Purchases of investment securities available for sale	(158,631)	(133,646)
Proceeds from calls, maturities and paydowns of investment securities available for sale	39,813	77,070
Proceeds from sale of investment securities available for sale	72,292	28,077
Purchases of other investments	(215)	0
Proceeds from sale of other investments	197	393
Net change in loans	36,659	22,338
Purchases of premises and equipment	(775)	(1,148)
Purchases of bank owned life insurance	(5,000)	0
Proceeds from sale of other real estate and repossessions	2,656	4,681
Net cash (used) provided by investing activities	(12,269)	375
Cash flows from financing activities:
Net change in deposits	2,329	32,962
Net change in demand notes payable to U.S. Treasury	(504)	(284)
Net change in securities sold under agreement to repurchase	13,607	4,634
Proceeds from FHLB borrowings	5,000	0
Repayments of FHLB borrowings	(5,000)	(7,000)
Restricted stock payout	9	0
Cash dividends paid on Series A preferred stock	(940)	(940)
Cash dividends paid on common stock	(333)	(337)
Net cash provided by financing activities	14,168	29,035
Net change in cash and cash equivalent	20,896	43,971
Cash and cash equivalents at beginning of period	23,977	31,340
Cash and cash equivalents at end of period	44,873	75,311
Cash paid during the year for:
Interest	8,613	11,146
Income taxes	132	1,700
Noncash investing and financing activities:
Change in unrealized gain on investment securities available for sale, net	(4,370)	(2,578)
Change in unrealized gain on derivative financial instruments, net	395	445
Transfer of loans to other real estate and repossessions	7,041	6,189
Financed portion of sale of other real estate	4,047	1,703
Accretion of Series A preferred stock	$ 106	$ 106